Background Ocular chronic graft versus host disease (oGVHD) seriously affects ocular surface, which often results in corneal ...

Background/aims Posterior capsule opacification (PCO) is the most frequent long-term complication after cataract surgery, ...

Dr Antonio Pinna, Istituto di Clinica Oculistica, Università degli Studi di Sassari, Viale San Pietro 43 A, 07100 Sassari, Italy. AIMS To identify and determine antibiotic susceptibility of coagulase ...

Background/Aims Patients have largely been excluded from discussions on the use of their health data in developing medical artificial intelligence (AI), despite being directly affected by its ...

Aims To determine the prevalence and clinicopathological features of malignant melanocytic lesions in specimens clinically diagnosed as pterygia. Methods This retrospective study analysed all ...

The rapid advancements in generative artificial intelligence are set to significantly influence the medical sector, particularly ophthalmology. Generative adversarial networks and diffusion models ...

Iberian Registry of Ocular Syphilis (IBERSOS) report 1: epidemiology, clinical spectrum and treatment outcomes of ocular syphilis in the Iberian Peninsula ...

3 Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USA 4 Brigham & Women's Hospital, Department of Medicine, Division of Preventative Medicine, Boston, Massachusetts, USA ...

Purpose To establish and validate a universal artificial intelligence (AI) platform for collaborative management of cataracts involving multilevel clinical scenarios and explored an AI-based medical ...

4 NIHR Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, UK Purpose To report the outcomes of intravitreal methotrexate (MTX) ...

Purpose To evaluate glaucoma prevalence and disease burden across Asian subregions from 2013 to 2040. Methods We conducted a systematic review and meta-analysis of 23 population-based studies of 1318 ...

Methods Our analysis included 12 364 adults aged 55–73 years from the UK Biobank cohort. Participants were assessed between 2006 and 2010 at baseline and were followed up until the early of 2021.